The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells - Candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia

Author: Niitsu N.   Higashihara M.   Honma Y.  

Publisher: Elsevier

ISSN: 0301-472X

Source: Experimental Hematology, Vol.30, Iss.11, 2002-11, pp. : 1273-1282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content